Skip to main content

and
  1. Article

    Open Access

    Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction

    Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their benefits occur also during hospitali...

    Filippo Trombara, Nicola Cosentino, Alice Bonomi in Cardiovascular Diabetology (2023)

  2. Article

    Open Access

    Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction

    Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on ...

    Marta Baviera, Stefano Genovese, Pierluca Colacioppo in Cardiovascular Diabetology (2022)

  3. No Access

    Chapter

    Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality

    Diabetes mellitus (DM) is an important risk factor for acute myocardial infarction (AMI) and a frequent co-morbidity in patients hospitalized with AMI, being present in about 30% of cases. Although current tre...

    Valentina Milazzo, Nicola Cosentino in Diabetes: from Research to Clinical Practi… (2021)

  4. Article

    Open Access

    Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus

    High-sensitivity C-reactive protein (hs-CRP) elevation frequently occurs in acute myocardial infarction (AMI) and is associated with adverse outcomes. Since diabetes mellitus (DM) is characterized by an underl...

    Claudia Lucci, Nicola Cosentino, Stefano Genovese in Cardiovascular Diabetology (2020)